By measuring levels of a modified protein, they could identify those who went on to
develop secondary tumours within two years, with more than 90 per cent accuracy.
Not exact matches
The time needed for breast cancer metastases (
secondary lesions caused by cells that have escaped from the original
tumour) to
develop varies between patients, and little is known about the mechanisms that govern latency (the dormant state of cells that have already spread through the body).
Part of the research is aimed at
developing a new prognostic «biomarker» — proteins present in the cancer that identify TNBC patients at high risk of metastasis (development of
secondary tumours).
Scientists from King's College London, funded by Breast Cancer Now, believe they have found a way to identify lymph - node positive breast cancer patients who are most likely to
develop incurable
secondary tumours (metastases) and those who are less at risk.